HeyJaredHematology / Oncology @Point of Care Podcasts
Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.
- Indexed episodes, last 90 days
- 6
- Latest publication
- Aug 15, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 24, 2026
Latest episodes
S32:E2 – Perioperative MIBC: Treatment Selection in Practice (opens the original)
Read excerpt
This expert-led podcast explores practical treatment selection in the evolving perioperative landscape for muscle-invasive bladder cancer. Faculty will discuss how to assess treatment eligibility, navigate immunotherapy-based and antibody-drug conjugate–based options, and coordinate care across specialties to support timely, individualized treatment decisions. Visit https://suitehome.atpointofcare.com/library/2744.02/page/0 to view the activity and CME/CE information, download the transcript, an
S32:E1 – Perioperative MIBC: Translating Trial Into Practice (opens the original)
Read excerpt
This expert-led podcast explores the rapidly evolving perioperative treatment landscape in muscle-invasive bladder cancer. Faculty will discuss pivotal data from NIAGARA, KEYNOTE-905, and KEYNOTE-B15, and consider how recent advances are expanding systemic treatment options, including for patients who are cisplatin-ineligible, and reshaping perioperative care. Visit https://suitehome.atpointofcare.com/library/2744.01/page/0 to view the activity and CME/CE information, download the transcript, an
S31:E2 – Matching Therapy to Biology: The Importance of PTCL Subtype (opens the original)
Read excerpt
Given the diversity of peripheral T-cell lymphoma (PTCL) subtypes, clinicians may need guidance choosing which therapy is most appropriate for each subtype. Join Dr. Steven Horwitz and Theresa Davey, PA-C, for a discussion of the PTCL treatment landscape and the evidence for matching epigenetic therapies to specific PTCL subtypes. Visit https://www.atpointofcare.com/library/2736.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluati
S31:E1 – Emerging Evidence: What Clinical Trials Reveal About Epigenetic Therapies in PTCL (opens the original)
Read excerpt
Relapsed/refractory peripheral T-cell lymphoma (PTCL) remains a significant treatment challenge. Join Dr. Stephen Horwitz and Theresa Davey as they review emerging clinical trial data on epigenetic therapies, including azacitidine, HDAC (histone deacetylase) inhibitors, and EZH (enhancer of zeste homolog)-targeted agents, and discuss how biology-driven treatment strategies may help personalize care and improve outcomes for patients with PTCL. Visit https://www.atpointofcare.com/library/2736.01/p
S31:E3 – Personalizing Care With Factor VIIIa Mimetics for Patients With Hemophilia A (opens the original)
Read excerpt
Join expert hematologists, Drs. Stacy Croteau and Guy Young, as they provide their expert opinion regarding strategies for personalizing care for patients with hemophilia A. Topics discussed in this podcast include an overview of the current and investigational therapeutic landscape and an in-depth dialogue where they review their shared decision-making strategies and best practices for individualized care in clinical practice. Visit [ https://www.atpointofcare.com/library/2723.02/page/0 ]( This
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.
See coverage about Hematology / Oncology @Point of Care Podcasts